Clinical Trial Update: IGF Inhibition With Xentuzumab Prior to Radical Prostatectomy [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating IGF-1/IGF-2 inhibition with Xentuzumab before radical prostatectomy in prostate cancer has completed. Results were posted on 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xentuzumab (Xentuzumab)

Snippet

Sponsor: University of Oxford | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-02-17